[Expert recommendations 2006 on the rationale for second-line therapy for non-small cell bronchial neoplasms].
Hilbe
Wolfgang
W
Medizinische Universität Innsbruck, Klinische Abteilung für Allgemeine Innere Medizin, Schwerpunkt Onkologie, Innsbruck, Austria. wolfgang.hilbe@i-med.ac.at
Aigner
Kurt
K
Dittrich
Christian
C
Eckmayr
Josef
J
Fiegl
Michael
M
Flicker
Martin
M
Forstner
Bernhard
B
Greil
Richard
R
Jamnig
Herbert
H
Krajnik
Gerhard
G
Lang
Alois
A
Mohn-Staudner
Andrea
A
Schinko
Herwig
H
Studnicka
Michael
M
Pirker
Robert
R
Ploner
Ferdinand
F
Rothmund
Johannes
J
Schiller
Lothar
L
Zabernigg
August
A
Zöchbauer-Müller
Sabine
S
D000970:Antineoplastic Agents / Q000008:administration & dosage*; D001317:Austria; D001984:Bronchial Neoplasms / Q000188:drug therapy*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy*; D017410:Practice Guidelines as Topic; D012955:Societies, Medical
D000970:Antineoplastic Agents